ClinicalTrials.gov
ClinicalTrials.gov Menu

Temodar and Sutent as Therapy for Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00304200
Recruitment Status : Terminated (Funding was inadequate to continue; Companies requested closure.)
First Posted : March 17, 2006
Last Update Posted : February 5, 2009
Sponsor:
Collaborators:
Pfizer
Schering-Plough
Information provided by:
Northern California Melanoma Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2007
  Actual Study Completion Date : January 2009
Publications: